NCT01801501View on ClinicalTrials.gov

Role of FGF-23 as a Prognosis Biomarker in Intensive Care Patients

CompletedOBSERVATIONAL
Enrollment

164

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

December 31, 2018

Conditions
SepsisAcute Kidney Injury
Trial Locations (1)

8380456

University of Chile Clinical Hospital, Santiago

All Listed Sponsors
lead

University of Chile

OTHER

NCT01801501 - Role of FGF-23 as a Prognosis Biomarker in Intensive Care Patients | Biotech Hunter | Biotech Hunter